
Tara L. Martinez
Examiner (ID: 12501)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 718 |
| Issued Applications | 367 |
| Pending Applications | 92 |
| Abandoned Applications | 264 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11798582
[patent_doc_number] => 09539301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Melanotropin ligands for skin care'
[patent_app_type] => utility
[patent_app_number] => 15/050671
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 78
[patent_no_of_words] => 50346
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050671
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050671 | Melanotropin ligands for skin care | Feb 22, 2016 | Issued |
Array
(
[id] => 11633878
[patent_doc_number] => 09655834
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-05-23
[patent_title] => 'Peptide, method and composition for inhibiting melanogenesis'
[patent_app_type] => utility
[patent_app_number] => 15/051305
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 2137
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15051305
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/051305 | Peptide, method and composition for inhibiting melanogenesis | Feb 22, 2016 | Issued |
Array
(
[id] => 14390847
[patent_doc_number] => 10308693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Antimicrobial peptides
[patent_app_type] => utility
[patent_app_number] => 15/115161
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 16836
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15115161
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/115161 | Antimicrobial peptides | Feb 16, 2016 | Issued |
Array
(
[id] => 12177334
[patent_doc_number] => 20180036270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'A METHOD OF PROTECTING AGAINST CARBONYL STRESS INDUCED ISCHEMIA-REPERFUSION INJURY IN THE DIABETIC BRAIN VIA ADMINISTRATION OF N-ACETYLCYSTEINE'
[patent_app_type] => utility
[patent_app_number] => 15/550149
[patent_app_country] => US
[patent_app_date] => 2016-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 13203
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550149
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550149 | A METHOD OF PROTECTING AGAINST CARBONYL STRESS INDUCED ISCHEMIA-REPERFUSION INJURY IN THE DIABETIC BRAIN VIA ADMINISTRATION OF N-ACETYLCYSTEINE | Feb 15, 2016 | Abandoned |
Array
(
[id] => 16518708
[patent_doc_number] => 10869910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Molecular design of recombinant protein drug
[patent_app_type] => utility
[patent_app_number] => 15/550751
[patent_app_country] => US
[patent_app_date] => 2016-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 38
[patent_no_of_words] => 7726
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550751 | Molecular design of recombinant protein drug | Feb 13, 2016 | Issued |
Array
(
[id] => 10797892
[patent_doc_number] => 20160144049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'CARRIERS FOR IMPROVED DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/017602
[patent_app_country] => US
[patent_app_date] => 2016-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24203
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/017602 | Carriers for improved drug delivery | Feb 5, 2016 | Issued |
Array
(
[id] => 12137068
[patent_doc_number] => 20180015151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'METHODS AND COMPOSITIONS FOR IMPROVED COGNITION'
[patent_app_type] => utility
[patent_app_number] => 15/548306
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13465
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548306
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548306 | Methods and compositions for improved cognition | Feb 4, 2016 | Issued |
Array
(
[id] => 10805307
[patent_doc_number] => 20160151464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'LOW VISCOSITY COMPOSITIONS COMPRISING A PEGYLATED GLA-DOMAIN CONTAINING PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 15/015630
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10941
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015630
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015630 | LOW VISCOSITY COMPOSITIONS COMPRISING A PEGYLATED GLA-DOMAIN CONTAINING PROTEIN | Feb 3, 2016 | Pending |
Array
(
[id] => 11016657
[patent_doc_number] => 20160213610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB'
[patent_app_type] => utility
[patent_app_number] => 15/008634
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 20453
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15008634
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/008634 | MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB | Jan 27, 2016 | Abandoned |
Array
(
[id] => 12125137
[patent_doc_number] => 20180008723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'MULTIMERIC COMPOUNDS OF A KRINGLE DOMAIN FROM THE HEPATOCYTE GROWTH FACTOR / SCATTER FACTOR (HGF/SF)'
[patent_app_type] => utility
[patent_app_number] => 15/545163
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12509
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545163 | MULTIMERIC COMPOUNDS OF A KRINGLE DOMAIN FROM THE HEPATOCYTE GROWTH FACTOR / SCATTER FACTOR (HGF/SF) | Jan 20, 2016 | Abandoned |
Array
(
[id] => 11074270
[patent_doc_number] => 20160271234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'TISSUE INHIBITOR OF METALLOPROTEINASES (Timp) LINKED TO GLYCOSYLPHOSPHATIDYLINOSITOL (Gpi) - ANCHORS FOR TREATMENT OF CANCER AND SKIN LESIONS'
[patent_app_type] => utility
[patent_app_number] => 15/000928
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20145
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15000928
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/000928 | TISSUE INHIBITOR OF METALLOPROTEINASES (Timp) LINKED TO GLYCOSYLPHOSPHATIDYLINOSITOL (Gpi) - ANCHORS FOR TREATMENT OF CANCER AND SKIN LESIONS | Jan 18, 2016 | Abandoned |
Array
(
[id] => 12125080
[patent_doc_number] => 20180008667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'CELL PENETRATING ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/543915
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27162
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543915
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/543915 | Cell penetrating antibodies | Jan 14, 2016 | Issued |
Array
(
[id] => 12117150
[patent_doc_number] => 20180000736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'METHODS FOR THE REGENERATION OF ARTICULAR CARTILAGE IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 15/541737
[patent_app_country] => US
[patent_app_date] => 2016-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14151
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541737
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541737 | METHODS FOR THE REGENERATION OF ARTICULAR CARTILAGE IN VIVO | Jan 6, 2016 | Abandoned |
Array
(
[id] => 16246099
[patent_doc_number] => 10745440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Peptides and nanoparticles for intracellular delivery of molecules
[patent_app_type] => utility
[patent_app_number] => 15/539619
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 25
[patent_no_of_words] => 38567
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539619
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539619 | Peptides and nanoparticles for intracellular delivery of molecules | Dec 22, 2015 | Issued |
Array
(
[id] => 14516531
[patent_doc_number] => 10335501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Cyclic peptides with enhanced nerve-binding selectively, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging
[patent_app_type] => utility
[patent_app_number] => 14/969877
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 45
[patent_no_of_words] => 9009
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14969877
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/969877 | Cyclic peptides with enhanced nerve-binding selectively, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging | Dec 14, 2015 | Issued |
Array
(
[id] => 19025855
[patent_doc_number] => 11925192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Beverage with collagen and additional additives
[patent_app_type] => utility
[patent_app_number] => 14/969519
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7721
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14969519
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/969519 | Beverage with collagen and additional additives | Dec 14, 2015 | Issued |
Array
(
[id] => 12117132
[patent_doc_number] => 20180000717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'PEPTIDIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES OF SAID COMPOUNDS, IN PARTICULAR COSMETIC USES'
[patent_app_type] => utility
[patent_app_number] => 15/535651
[patent_app_country] => US
[patent_app_date] => 2015-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8799
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535651
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/535651 | Peptidic compounds, compositions comprising them and uses of said compounds, in particular cosmetic uses | Dec 13, 2015 | Issued |
Array
(
[id] => 12523845
[patent_doc_number] => 10004779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Elastin protective polyphenolics and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 14/962592
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10384
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962592
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962592 | Elastin protective polyphenolics and methods of using the same | Dec 7, 2015 | Issued |
Array
(
[id] => 13566251
[patent_doc_number] => 20180334673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => CELL PENETRATING MOLECULE
[patent_app_type] => utility
[patent_app_number] => 15/531683
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531683
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/531683 | CELL PENETRATING MOLECULE | Nov 30, 2015 | Abandoned |
Array
(
[id] => 11356390
[patent_doc_number] => 09533028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Complement factor B analogs and their uses'
[patent_app_type] => utility
[patent_app_number] => 14/951565
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 34627
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14951565
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/951565 | Complement factor B analogs and their uses | Nov 24, 2015 | Issued |